By Steve Gorman (Reuters) – More than 200 people from across the United States have fallen ill, 84 of them hospitalized, from an ongoing salmonella outbreak linked to raw turkey products that prompted a second voluntary...
Read MoreBy Lisa Rapaport (Reuters Health) – – As a growing number of people live decades after a cancer diagnosis, doctors and scientists are developing treatment guidelines for survivors. But a U.S. report suggests more...
Read More
By Lisa Rapaport (Reuters Health) – – Millions of Americans have searched Google for...
Read More(Reuters) – Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients. The results showed the drug, Bavencio, in...
Read More
By Linda Carroll (Reuters Health) – – For years, researchers have been studying...
Read MoreBy Lisa Rapaport (Reuters Health) – – Isotretinoin, a drug for severe chronic acne, has long been linked to miscarriages, birth defects and other serious problems, but a research review suggests much of data on the...
Read More(Reuters) – The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc’s Elzonris for the treatment of a rare blood disease in adults and children aged two years and above. This is the first...
Read More
HAVANA (Reuters) – Cuba’s President Miguel Diaz-Canel said more than 90 percent of the...
Read MoreBy Manas Mishra (Reuters) – The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceuticals Inc’s rare blood disorder drug Ultomiris, an early backing that also solidifies the company’s...
Read More
